case 2: cdk4/6 inhibitors in er breast cancer
Published 4 years ago • 130 plays • Length 4:37Download video MP4
Download video MP3
Similar videos
-
4:15
case 2: choosing a cdk4/6 inhibitor in er breast cancer
-
6:13
case 2: cdk4/6 inhibitor recommendations in er breast cancer
-
4:17
cdk4/6 inhibitors & endocrine therapy in breast cancer
-
5:35
case 2: treatment recommendations for er breast cancer
-
3:08
case 2: er breast cancer
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
0:37
cdk4/6 inhibitors in her2-negative breast cancer based on phase iii monaleesa-7 trial
-
1:09:24
raising the bar in hr /her2- early breast cancer: cdk4 and 6 inhibitors
-
1:36
dr. mahtani on the use of cdk 4/6 inhibitors in metastatic er breast cancer
-
21:08
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - second-line therapy
-
2:19
cdk 4/6 inhibitors for patients with recurrent er /her2- breast cancer: 2023 best of breast
-
1:26
ribecca: ribociclib, a cdk4/6 inhibitor in er breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
14:51
expert perspectives: targeting advanced er metastatic breast cancer with cdk 4/6 inhibitors
-
3:50
cdk4/6 inhibitors in metastatic breast cancer
-
17:54
expert perspectives: cdk 4/6 inhibitors for er breast cancer: current data and clinical use
-
3:32
case 2: defining strongly versus less strongly er breast cancer